Table 1. Immunohistochemical results of glucose metabolism-related genes in SPN.

Case#	Gender	Age	Tumor Size (cm)	18FDG-uptake pattern	GLUT1	HK1	ENO2	PKM2	Ki-67	Necrosis
1	Female	25	5.6	Hot	+	+	+	+/-	< 1%	-
2	Female	46	5	Defective	-	++	+	+	< 1%	-
3	Female	38	3.5	Mixed	+	++	+	N/A	< 1%	+
4	Female	28	5	Defective	+	N/A	+	N/A	< 1%	+
5	Female	28	6.8	Hot	+	N/A	+	N/A	< 1%	+
6	Female	24	8.2	Hot	+	++	+	+	< 1%	-
7	Female	32	1.7	Hot	+	++	+	+	1-2%	-
8	Female	25	4.9	Defective	+	++	+	+	1–2%	-
9	Female	31	5.3	Defective	+	N/A	+	N/A	0%	+
10	Female	46	6.5	Defective	+	N/A	+	N/A	0%	+
11	Female	45	2.3	Mixed	+	++	+	+	< 1%	-
12	Female	12	10.1	Mixed	+	++	+	+	3% ≤	-
13	Female	25	12.3	Hot	+	N/A	+	N/A	1–2%	+
14	Female	35	1.3	Hot	+	++	+	+	1–2%	-
15	Female	24	5.7	Hot	+	++	+	+	< 1%	-
16	Female	62	1.5	Hot	+	++	+	+	< 1%	-
17	Female	35	1.6	Mixed	+	++	+	+	< 1%	-
18	Female	14	6.9	Hot	-	++	+	+/-	3% ≤	-
19	Female	19	3.5	Mixed	-	++	+	+	1–2%	-
20	Female	47	4.2	Hot	+	++	+	+	< 1%	-
21	Male	30	3.8	Hot	+	++	+	+	< 1%	-
22	Female	48	1.5	Defective	+	++	+	+	< 1%	-
23	Female	41	2.5	Defective	+	N/A	+	N/A	< 1%	+
24	Female	38	6.5	Hot	+	N/A	+	N/A	< 1%	+
25	Female	46	2	Defective	+	++	+	+	1–2%	-
26	Female	28	8	Defective	+	+	+	+/-	3% ≤	-
27	Female	16	7	Hot	+	N/A	+	N/A	< 1%	-
28	Female	45	3	-	-	N/A	+	+/-	< 1%	+
29	Female	43	5.2	Defective	-	N/A	+	+/-	< 1%	+
30	Female	22	8.5	Hot	+	+	+	+	1–2%	-
31	Female	40	8.3	Hot	+	++	+	+	1–2%	-
32	Female	35	1.6	Hot	+	++	+	+	< 1%	-
33	Female	38	2	Hot	+	++	+	N/A	1–2%	-
34	Female	40	2.7	Hot	+	+	+	N/A	< 1%	-
35	Female	42	1.5	Hot	+	++	+	+	1–2%	-
36	Female	23	5	Hot	+	++	+	+/-	< 1%	-

N/A; not available due to necrosis, immunohistochemistry score (-; negative, +/-; weak, +; moderate, ++; strong)